Radioiodine therapy versus antithyroid medications for Graves' disease
Author:
Affiliation:
1. Affiliated XinHua Hospital of Medical School Shanghai Jiaotong University; Nuclear Medicine; Kongjiang Road 1665 Shanghai Shanghai China 200092
2. Putuo Liqun Hospital; Stomatology; Shanghai Shanghai China 200092
Publisher
Wiley
Subject
Pharmacology (medical)
Reference80 articles.
1. Graves' disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery;Abraham-Nordling;Thyroid,2005
2. Thyroid hormone state and quality of life at long-term follow-up after randomized treatment of Graves' disease;Abraham-Nordling;European Journal of Endocrinology,2007
3. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study;Laurberg;European Journal of Endocrinology,2008
4. Quality of life aspects and costs in treatment of Graves' hyperthyroidism with antithyroid drugs, surgery, or radioiodine: results from a prospective, randomized study;Ljunggren;Thyroid,1998
5. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism, the thyroid study group;Tallstedt;New England Journal of Medicine,1992
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy of Anti-Thyroid Medications in Patients with Graves’ Disease;BMC Endocrine Disorders;2024-09-06
2. Low molecular inverse agonist of the thyrotropin receptor is active both intraperitoneal and oral administration;Российский физиологический журнал им И М Сеченова;2024-06-28
3. A comparison of cardiovascular disease, cancer, mortality, and Graves' ophthalmopathy following treatment for hyperthyroidism: A Bayesian network meta‐analysis;World Journal of Surgery;2024-01-18
4. How Age Affects Graves’ Orbitopathy—A Tertiary Center Study;Journal of Clinical Medicine;2024-01-04
5. Low Molecular Weight Thyrotropin Receptor Inverse Agonist Is Active upon Both Intraperitoneal and Oral Administration;Journal of Evolutionary Biochemistry and Physiology;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3